Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Agnello
Vincent
V
Mecucci
Cristina
C
Casato
Milvia
M
D000998:Antiviral Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000145:classification; D002999:Clone Cells; D003449:Cryoglobulinemia / Q000150:complications*; D003450:Cryoglobulins / Q000145:classification; D019938:Cyclin D1 / Q000378:metabolism; D016174:Hepacivirus; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications*; D013160:Splenic Neoplasms / Q000150:complications*
D000998:Antiviral Agents; D003450:Cryoglobulins; D019938:Cyclin D1